Retinoid X receptor 3D structures
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 5: | Line 5: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | *Retinoid X receptor α | + | *Retinoid X receptor α; Domains – DBD 33-115; LBD 223-462 |
**[[3nsp]], [[6hn6]], [[1g1u]] - hRXR LBD – human<br /> | **[[3nsp]], [[6hn6]], [[1g1u]] - hRXR LBD – human<br /> | ||
| Line 17: | Line 17: | ||
**[[1fby]] - hRXR LBD + 9-''cis'' retinoic acid<br /> | **[[1fby]] - hRXR LBD + 9-''cis'' retinoic acid<br /> | ||
**[[3nsq]] - hRXR LBD + antagonist<br /> | **[[3nsq]] - hRXR LBD + antagonist<br /> | ||
| - | **[[5zqu]] - hRXR LBD + naphthalene derivative <br /> | + | **[[5zqu]], [[7cfo]] - hRXR LBD + naphthalene derivative <br /> |
**[[6jno]] - hRXR LBD + ligand<br /> | **[[6jno]] - hRXR LBD + ligand<br /> | ||
| - | **[[3fug]], [[5mk4]] - hRXR LBD + NCOA2 peptide<br /> | + | **[[3fug]], [[5mk4]], [[7bk4]] - hRXR LBD + NCOA2 peptide<br /> |
| + | **[[6jnr]] - hRXR LBD + SRC1 peptide<br /> | ||
**[[3fc6]] – hRXR LBD + NR1H3 protein<br /> | **[[3fc6]] – hRXR LBD + NR1H3 protein<br /> | ||
**[[3r29]] - hRXR LBD + corepressor peptide SMRT2<br /> | **[[3r29]] - hRXR LBD + corepressor peptide SMRT2<br /> | ||
| Line 25: | Line 26: | ||
**[[4ozr]], [[4ozt]] - hRXR LBD + ecdysone receptor <br /> | **[[4ozr]], [[4ozt]] - hRXR LBD + ecdysone receptor <br /> | ||
**[[4j5w]] - hRXR LBD + orphan nuclear receptor PXR<br /> | **[[4j5w]] - hRXR LBD + orphan nuclear receptor PXR<br /> | ||
| + | **[[6xwh]] - hRXR DBD + DR0 response element <br /> | ||
**[[1dkf]] – mRXR LBD + mRAR LBD – mouse<br /> | **[[1dkf]] – mRXR LBD + mRAR LBD – mouse<br /> | ||
| Line 30: | Line 32: | ||
**[[1dsz]] - hRXR LBD + hRAR LBD + DNA<br /> | **[[1dsz]] - hRXR LBD + hRAR LBD + DNA<br /> | ||
| - | **[[3a9e]] - hRXR LBD + hRAR LBD + NCOA2 peptide<br /> | + | **[[3a9e]], [[7aos]] - hRXR LBD + hRAR LBD + NCOA2 peptide<br /> |
**[[3r2a]] - hRXR LBD + corepressor peptide SMRT2 + antagonist<br /> | **[[3r2a]] - hRXR LBD + corepressor peptide SMRT2 + antagonist<br /> | ||
**[[3h0a]], [[1fm6]], [[1fm9]], [[1k74]], [[5ji0]] - hRXR LBD + PPAR-γ + 9-''cis'' retinoic acid + NCOA2 peptide<br /> | **[[3h0a]], [[1fm6]], [[1fm9]], [[1k74]], [[5ji0]] - hRXR LBD + PPAR-γ + 9-''cis'' retinoic acid + NCOA2 peptide<br /> | ||
| Line 38: | Line 40: | ||
**[[3ozj]] - hRXR LBD + bigelovin + NCOA2 peptide<br /> | **[[3ozj]] - hRXR LBD + bigelovin + NCOA2 peptide<br /> | ||
**[[3pcu]] - hRXR LBD + rutamarin + NCOA2 peptide<br /> | **[[3pcu]] - hRXR LBD + rutamarin + NCOA2 peptide<br /> | ||
| - | **[[2zxz]], [[2zy0]], [[3r5m]], [[1mzn]], [[1mv9]], [[1mvc]], [[4k4j]], [[4k6i]], [[4m8e]], [[4m8h]], [[5lyq]] - hRXR LBD + agonist + NCOA2 peptide<br /> | + | **[[7a77]] - hRXR LBD + palmitate + NCOA2 peptide<br /> |
| + | **[[2zxz]], [[2zy0]], [[3r5m]], [[1mzn]], [[1mv9]], [[1mvc]], [[4k4j]], [[4k6i]], [[4m8e]], [[4m8h]], [[5lyq]], [[7b88]], [[7b9o]] - hRXR LBD + agonist + NCOA2 peptide<br /> | ||
**[[2acl]] - hRXR LBD + agonist + oxysterols receptor α<br /> | **[[2acl]] - hRXR LBD + agonist + oxysterols receptor α<br /> | ||
**[[6sjm]] - hRXR LBD + biphenyl + NCOA2 peptide<br /> | **[[6sjm]] - hRXR LBD + biphenyl + NCOA2 peptide<br /> | ||
**[[3kwy]] - hRXR LBD + triphenyltin + NCOA2 peptide<br /> | **[[3kwy]] - hRXR LBD + triphenyltin + NCOA2 peptide<br /> | ||
**[[3e94]] - hRXR LBD + tributylin + NCOA2 peptide<br /> | **[[3e94]] - hRXR LBD + tributylin + NCOA2 peptide<br /> | ||
| + | **[[7nke]], [[7uw2]], [[7uw4]] - hRXR LBD + activator + NCOA2 peptide<br /> | ||
**[[2p1t]], [[2p1u]], [[2p1v]], [[4rfw]], [[4rmc]], [[4rme]], [[4rmd]] - hRXR LBD + retinoid + NCOA2 peptide<br /> | **[[2p1t]], [[2p1u]], [[2p1v]], [[4rfw]], [[4rmc]], [[4rme]], [[4rmd]] - hRXR LBD + retinoid + NCOA2 peptide<br /> | ||
**[[5ec9]] - hRXR LBD + coactivator TIF2 peptide + activator<br /> | **[[5ec9]] - hRXR LBD + coactivator TIF2 peptide + activator<br /> | ||
| Line 52: | Line 56: | ||
**[[4j5x]] - hRXR LBD + orphan nuclear receptor PXR + phosphonic acid derivative<br /> | **[[4j5x]] - hRXR LBD + orphan nuclear receptor PXR + phosphonic acid derivative<br /> | ||
**[[1r0n]], [[1ynw]] - hRXR DBD + DR3 response element + vitamin D3 receptor <br /> | **[[1r0n]], [[1ynw]] - hRXR DBD + DR3 response element + vitamin D3 receptor <br /> | ||
| + | **[[6xwg]] - hRXR DBD + DR3 response element + RAR-a <br /> | ||
| + | **[[8hbm]] - hRXR LBD + bile acid receptor + DNA<br /> | ||
| + | **[[7qaa]] - mRXR LBD + hRAR + activator<br /> | ||
| + | **[[7pdq]] - mRXR LBD + activator + hNCOA2 peptide<br /> | ||
| + | **[[7pdt]] - mRXR LBD (mutant) + activator + hNCOA2 peptide<br /> | ||
*Retinoid X receptor α quaternary complex | *Retinoid X receptor α quaternary complex | ||
| Line 73: | Line 82: | ||
**[[1h9u]] – hRXR LBD + agonist<br /> | **[[1h9u]] – hRXR LBD + agonist<br /> | ||
**[[5hjp]], [[5i4v]] - hRXR LBD + oxysterols receptor LXR-β + agonist<br /> | **[[5hjp]], [[5i4v]] - hRXR LBD + oxysterols receptor LXR-β + agonist<br /> | ||
| + | **[[7a78]] - hRXR LBD + palmitate + NCOA2 peptide<br /> | ||
**[[5kyj]], [[5kya]] - hRXR LBD (mutant) + oxysterols receptor LXR-β + modulator <br /> | **[[5kyj]], [[5kya]] - hRXR LBD (mutant) + oxysterols receptor LXR-β + modulator <br /> | ||
**[[1xdk]] - mRXR LBD + mRAR LBD + thyroid receptor associated protein<br /> | **[[1xdk]] - mRXR LBD + mRAR LBD + thyroid receptor associated protein<br /> | ||
| Line 78: | Line 88: | ||
*Retinoid X receptor γ | *Retinoid X receptor γ | ||
| - | **[[2gl8]] – hRXR LBD | + | **[[2gl8]] – hRXR LBD<br /> |
| + | **[[7a79]] - hRXR LBD + palmitate + NCOA2 peptide<br /> | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
3D structures of retinoid X receptor
Updated on 12-October-2023
